Diagnostic And Consulting Center St. Georgi Pobedonosetc EOOD
- Address
- Ul. Vanche Mihaylov 1, 8000 Burgas, Bulgaria
Diagnostic And Consulting Center St. Georgi Pobedonosetc EOOD
This diagnostic and consulting center specializes in cardiovascular disease research and prevention, with particular expertise in advanced lipid-lowering therapies and primary prevention strategies. The facility focuses on evaluating innovative treatments aimed at reducing major adverse cardiovascular events in high-risk patient populations.
- Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
- Advanced cholesterol management and lipid-lowering therapies including PCSK9 inhibitors
- Major adverse cardiovascular event (MACE) prevention studies
The center conducts rigorous randomized, double-blind, placebo-controlled trials to assess novel therapeutic interventions in cardiovascular medicine. Their research encompasses comprehensive evaluation of treatments designed to prevent cardiovascular death, myocardial infarction, ischemic stroke, and urgent coronary revascularization in patients at elevated cardiovascular risk, contributing valuable clinical evidence to advance preventive cardiology.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Novartis Pharma AG1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG4trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Diagnostic And Consulting Center St. Georgi Pobedonosetc EOOD
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Pelacarsen (TQJ230) in Reducing Major Cardiovascular Events in Patients with Established Cardiovascular Disease: A Randomized, Double-Blind, Placebo-Controlled Trial | Novartis Pharma AG | Phase III | Not Recruiting | Mar 2020 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Inclisiran | 2 | Unknown | 2022-04-08 | 2022-04-08 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.